These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 23746323)
1. Words of wisdom. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Inman BA Eur Urol; 2013 Jul; 64(1):171-2. PubMed ID: 23746323 [No Abstract] [Full Text] [Related]
2. Words of wisdom. Re: Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Solsona E Eur Urol; 2014 Apr; 65(4):847-8. PubMed ID: 24559905 [No Abstract] [Full Text] [Related]
3. Intravesical sealing of the distal ureter in nephroureterectomy. Sesmero JH; Redondo CC; Delgado MC; Royo FC; Tesedo VR; Oceja JM Arch Esp Urol; 2010 Apr; 63(3):223-9. PubMed ID: 20431186 [TBL] [Abstract][Full Text] [Related]
8. The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. Laguna MP; de la Rosette JJ J Urol; 2001 Dec; 166(6):2017-22. PubMed ID: 11696698 [TBL] [Abstract][Full Text] [Related]
9. Re: Hemal et al.: Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning (Urology 2011;78:357-364). Park SY; Rha KH Urology; 2011 Dec; 78(6):1444; author reply 1444-5. PubMed ID: 22137715 [No Abstract] [Full Text] [Related]
10. Hand-assisted laparoscopic nephroureterectomy for upper urinary-tract transitional-cell carcinoma. Munver R; Del Pizzo JJ; Sosa RE J Endourol; 2004 May; 18(4):351-8. PubMed ID: 15253785 [TBL] [Abstract][Full Text] [Related]
11. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Wood DP J Urol; 2014 Feb; 191(2):348-9. PubMed ID: 24411846 [No Abstract] [Full Text] [Related]
12. Safer nephroureterectomy in the treatment of transitional cell carcinoma of the upper urinary tract. Perimenis P; Barbalias G Br J Urol; 1990 Dec; 66(6):667. PubMed ID: 2265351 [No Abstract] [Full Text] [Related]